The mechanism of honokiol-induced intracellular Ca2+ rises and apoptosis in human glioblastoma cells.

Liang WZ, Chou CT, Chang HT, Cheng JS, Kuo DH, Ko KC, Chiang NN, Wu RF, Shieh P, Jan CR.
Chem Biol Interact. 2014 Aug 7;221C:13-23. [Epub ahead of print]

Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.
Hahm ER, Sakao K, Singh SV.
Prostate. 2014 Jul 7.  [Epub ahead of print]

Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
Lai YJ, Lin CI, Wang CL, Chao JI.
J Cell Biochem. 2014 Jun 6. [Epub ahead of print]

Honokiol suppresses renal cancer cells’ metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling.
Li W, Wang Q, Su Q, Ma D, An C, Ma L, Liang H.
Mol Cells. 2014 May;37(5):383-8. Epub 2014 May 8.

[Honokiol combined with Gemcitabine synergistically inhibits the proliferation of human Burkitt lymphoma cells and induces their apoptosis].
Zhang MW, Xu XJ, Fan JX, Hung YX, Ye YB, Wang J, Guo KY.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):93-8. Chinese.

Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, Chen ZG, Arbiser JL, Shin DM.
PLoS One. 2014 Feb 25;9(2):e86369. doi: 10.1371/journal.pone.0086369. eCollection 2014.

Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D.
Mol Oncol. 2014 May;8(3):565-80. Epub 2014 Jan 15.

[Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
Cheng Z, Xue F, Wang S, Wang F, Liang L, Bai P, Bian Y, Wan J.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Feb;30(2):143-6. Chinese.

Honokiol inhibits androgen receptor activity in prostate cancer cells.
Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV.
Prostate. 2014 Apr;74(4):408-20. doi: 10.1002/pros.22762. Epub 2013 Dec 11.

Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition.
Joo YN, Eun SY, Park SW, Lee JH, Chang KC, Kim HJ.
Int J Oncol. 2014 Jan;44(1):187-94.Epub 2013 Nov 15.

Synergic effects of artemisinin and resveratrol in cancer cells.
Li P, Yang S, Dou M, Chen Y, Zhang J, Zhao X.
J Cancer Res Clin Oncol. 2014 Jul 22. [Epub ahead of print]

Artemisinin inhibits neuroblastoma proliferation through activation of AHP-activated protein kinase (AMPK) signaling.
Tan WQ, Chen G, Jia B, Ye M.
Pharmazie. 2014 Jun;69(6):468-72.

Differential Effect of Artemisinin Against Cancer Cell Lines.
Tilaoui M, Mouse HA, Jaafari A, Zyad A.
Nat Prod Bioprospect. 2014;4:189-196. Epub 2014 Jun 5.

Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.
Goodrich SK, Schlegel CR, Wang G, Belinson JL.
Future Oncol. 2014 Mar;10(4):647-54. 13.228.

[Artemisinin: a natural product for fighting against cancer].
Takatani-Nakase T.
Nihon Yakurigaku Zasshi. 2014 Feb;143(2):61-4. Review. Japanese. No abstract available.

Biological activities and potential health benefits of polysaccharides from Poria cocos and their derivatives.
Sun Y.
Int J Biol Macromol. 2014 Jul;68:131-4. Epub 2014 Apr 18.

Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.
Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu A, Sliva D.
Int J Oncol. 2013 Jun;42(6):1869-74. Epub 2013 Apr 16. Erratum in: Int J Oncol. 2014 May;44(5):1781. Thyagarajan-Sahu, Anita [added].

Ameliorative Action of Curcumin in Cisplatin-mediated Hepatotoxicity: An In Vivo Study in Wistar Rats.
Waseem M, Pandey P, Tomar B, Raisuddin S, Parvez S.
Arch Med Res. 2014 Jul 28. pii: S0188-4409(14)00162-3. [Epub ahead of print]

Therapeutic applications of curcumin for patients with pancreatic cancer.
Kanai M.
World J Gastroenterol. 2014 Jul 28;20(28):9384-9391. Review.

Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice.
Kim H, Park J, Tak KH, Bu SY, Kim E.
In Vitro Cell Dev Biol Anim. 2014 Jul 16. [Epub ahead of print]

Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols.
Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB.
Arch Biochem Biophys. 2014 Jun 16. pii: S0003-9861(14)00208-2. [Epub ahead of print] Review.

Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways.
Xue X, Yu JL, Sun DQ, Kong F, Qu XJ, Zou W, Wu J, Wang RM.
Asian Pac J Cancer Prev. 2014;15(9):3987-92.

Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells.
Zhao SF, Zhang X, Zhang XJ, Shi XQ, Yu ZJ, Kan QC.
Asian Pac J Cancer Prev. 2014;15(8):3363-8.

Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.
Ajazuddin, Alexander A, Qureshi A, Kumari L, Vaishnav P, Sharma M, Saraf S, Saraf S.
Fitoterapia. 2014 Sep;97C:1-14. Epub 2014 May 23. Review.

Curcumin: a promising agent targeting cancer stem cells.
Zang S, Liu T, Shi J, Qiao L.
Anticancer Agents Med Chem. 2014;14(6):787-92.

Identification of mitochondria-targeting anticancer compounds by an in vitro strategy.
Zhang X, Zhang S, Zhu S, Chen S, Han J, Gao K, Zeng JZ, Yan X.
Anal Chem. 2014 Jun 3;86(11):5232-7. doi: 10.1021/ac500918g. Epub 2014 May 21.

Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
Wu J, Tang Q, Zhao S, Zheng F, Wu Y, Tang G, Hahn SS.
Int J Oncol. 2014 Jul;45(1):95-103. Epub 2014 May 6.

Curcumin, a component of golden spice: From bedside to bench and back.
Prasad S, Gupta SC, Tyagi AK, Aggarwal BB.
Biotechnol Adv. 2014 Apr 30. pii: S0734-9750(14)00051-2. [Epub ahead of print] Review.

Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
Chiablaem K, Lirdprapamongkol K, Keeratichamroen S, Surarit R, Svasti J.
Anticancer Res. 2014 Apr;34(4):1857-64.